Stryker Corporation

New York Stock Exchange
Back to all articles
Slightly Bearish -15

Stryker Corporation $SYK Shares Bought by Azzad Asset Management Inc ...

📈 Azzad Asset Management Inc. raised its stake in Stryker by 1,006.4% to 6,406 shares worth $2.1 million in Q1.

📉 VP M Kathryn Fink sold 5,220 shares for $1.48 million, while Director Ronda E. Stryker sold 310,000 shares for $96.8 million in May.

💰 Corporate insiders collectively sold over 323,000 shares worth more than $100 million in the last quarter.

📊 Q1 earnings of $2.60 EPS missed analyst estimates of $2.98, with revenue of $6.02 billion missing the $6.34 billion forecast.

📈 Revenue grew 2.6% year-over-year to $6.02 billion, maintaining a 13.20% net margin and 23.42% return on equity.

🎯 Full-year 2026 EPS guidance is set between $14.90 and $15.10, slightly below analyst expectations of $14.98.

💵 A quarterly dividend of $0.88 per share was declared with an ex-dividend date of June 30th and a yield of 1.1%.

📉 The stock trades at a P/E ratio of 38.18 with a market capitalization of $126.46 billion.

🏥 Stryker operates in orthopedics, surgical equipment, neurotechnology, and patient-handling across global healthcare facilities.

Bullish Signals
  • Institutional ownership remains strong at 77.09%, with Azzad Asset Management significantly increasing its position by over 1,000%.
  • Multiple new institutional investors entered positions in Q3 and Q4, including Godfrey Financial Associates, Sankala Group, United Financial Planning Group, Atlas Capital Advisors, and DJE Kapital AG.
  • The company reported year-over-year revenue growth of 2.6%, demonstrating continued top-line expansion despite missing earnings estimates.
  • Stryker maintains a healthy balance sheet with a debt-to-equity ratio of 0.62, a quick ratio of 1.25, and a current ratio of 2.11.
  • The company declared a quarterly dividend of $0.88 per share, providing a 1.1% yield to shareholders.
Risk Factors
  • Q1 earnings per share of $2.60 missed the consensus estimate of $2.98 by $0.38.
  • Revenue of $6.02 billion fell short of analyst estimates of $6.34 billion.
  • Significant insider selling occurred in May, with VP M Kathryn Fink and Director Ronda E. Stryker reducing their holdings by 28.44% and 13.87% respectively.
  • Corporate insiders sold a total of 323,264 shares worth $100.6 million in the last quarter.
  • Full-year 2026 EPS guidance of $14.90-$15.10 is below analyst expectations of $14.98.
Full Analysis
Stryker Corporation (NYSE:SYK) saw significant changes in institutional ownership during the first quarter, led by Azzad Asset Management Inc., which increased its stake by 1,006.4% to hold 6,406 shares valued at $2.1 million. Several other firms, including Godfrey Financial Associates and Sankala Group, established new positions ranging from $26,000 to $28,000 each, while institutional investors collectively own 77.09% of the company's stock. Corporate insiders executed substantial sales in May, with VP M Kathryn Fink selling 5,220 shares for approximately $1.48 million and Director Ronda E. Stryker offloading 310,000 shares worth roughly $96.8 million. These transactions resulted in a combined insider sale of over 323,000 shares valued at more than $100 million during the last quarter, reducing corporate insider ownership to 4.60%. Financially, Stryker reported Q1 earnings of $2.60 per share, missing analyst estimates of $2.98, alongside revenue of $6.02 billion that fell short of the $6.34 billion consensus. Despite the miss, the company maintained a 13.20% net margin and 23.42% return on equity, with revenue growing 2.6% year-over-year. The stock trades at a market cap of $126.46 billion with a P/E ratio of 38.18. Looking ahead, Stryker has provided full-year 2026 guidance for EPS between $14.90 and $15.10, slightly below the analyst expectation of $14.98. The company also declared a quarterly dividend of $0.88 per share, payable on July 31st to shareholders of record by June 30th, representing an annualized yield of 1.1% and a payout ratio of 40.74%.